https://medicaex.com/businesswire/elispot-and-fluorospot-assay-market-report-2022-use-of-fluorospot-assays-for-multiple-analyte-detection-in-single-well-presents-opportunities-researchandmarkets-com-3/ 2022-11-25T17:12:12+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-zrm3OY.jpeg https://medicaex.com/businesswire/u-s-patient-engagement-solutions-market-report-2022-surge-in-adoption-of-telemedicine-increasing-healthcare-consumerism-and-rising-integration-across-healthcare-it-platforms-boosts-growth-resear-2/ 2022-11-25T17:12:11+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-yiwvO9.jpeg https://medicaex.com/businesswire/multiphoton-microscopy-global-market-report-2022-non-invasive-nature-driving-adoption-worldwide-researchandmarkets-com/ 2022-11-25T17:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-7WphRs.jpeg https://medicaex.com/businesswire/elispot-and-fluorospot-assay-market-report-2022-use-of-fluorospot-assays-for-multiple-analyte-detection-in-single-well-presents-opportunities-researchandmarkets-com-2/ 2022-11-25T17:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-uiiRqy.jpeg https://medicaex.com/businesswire/elispot-and-fluorospot-assay-market-report-2022-use-of-fluorospot-assays-for-multiple-analyte-detection-in-single-well-presents-opportunities-researchandmarkets-com/ 2022-11-25T17:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-rehz50.jpeg https://medicaex.com/businesswire/migraine-digital-marketing-trends-report-2022-assessment-of-pharma-companys-assets-in-branded-websites-for-patients-and-healthcare-professionals-hcps-mobile-apps-and-social-media-accounts-res/ 2022-11-25T17:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-YzLA5o.jpeg https://medicaex.com/businesswire/u-s-patient-engagement-solutions-market-report-2022-surge-in-adoption-of-telemedicine-increasing-healthcare-consumerism-and-rising-integration-across-healthcare-it-platforms-boosts-growth-resear/ 2022-11-25T17:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-XoMU5X.jpeg https://medicaex.com/businesswire/medical-simulation-global-market-report-2022-increasing-awareness-of-the-benefits-of-simulation-based-medical-learning-drives-growth-researchandmarkets-com/ 2022-11-25T16:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-Lv1xNJ.jpeg https://medicaex.com/businesswire/global-laryngoscope-market-2022-to-2031-players-include-ambu-hill-rom-holdings-inc-karl-storz-and-medtronic-researchandmarkets-com/ 2022-11-25T16:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-Ll89l4.jpeg https://medicaex.com/businesswire/global-glycomics-glycobiology-market-report-2022-glycomics-applications-in-precision-medicine-presents-lucrative-opportunities-researchandmarkets-com/ 2022-11-25T15:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-18OjhG.jpeg https://medicaex.com/businesswire/united-states-liquid-biopsy-market-report-2022-industry-trends-growth-outlook-impact-of-covid-19-company-analysis-2021-2027-researchandmarkets-com/ 2022-11-25T14:12:16+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-oJduZK.jpeg https://medicaex.com/businesswire/united-states-molecular-diagnostics-market-analysis-report-2022-a-12-5-billion-market-by-2027-industry-trends-growth-insights-impact-of-covid-19-company-analysis-researchandmarkets-com/ 2022-11-25T14:12:16+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-1wNuHG.jpeg https://medicaex.com/businesswire/global-digital-health-market-report-2022-increasing-adoption-of-digital-healthcare-presents-further-opportunities-for-growth-researchandmarkets-com/ 2022-11-25T14:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-AIvAym.jpeg https://medicaex.com/businesswire/north-america-human-papillomavirus-vaccine-market-report-2022-increase-in-prevalence-of-hpv-associated-diseases-spurs-growth-researchandmarkets-com/ 2022-11-25T14:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-9H1q5N.jpeg https://medicaex.com/businesswire/hologic-to-showcase-portfolio-of-comprehensive-breast-and-skeletal-health-solutions-at-rsna-2022-3/ 2022-11-25T13:12:12+00:00 https://medicaex.com/wp-content/uploads/2022/11/Hologic_Main_Logo_Small_White_cropped-sJb9zm.jpeg https://medicaex.com/businesswire/aptorum-announces-publication-of-a-co-authored-paper-on-development-and-validation-of-a-sensitive-liquid-chromatography-with-time-of-flight-mass-spectrometry-assay-for-in-vivo-pharmacokinetic-study-2/ 2022-11-25T13:12:12+00:00 https://medicaex.com/wp-content/uploads/2022/11/aptorum_hori_HQ-oYWoVd.jpeg https://medicaex.com/businesswire/hologic-to-showcase-portfolio-of-comprehensive-breast-and-skeletal-health-solutions-at-rsna-2022-2/ 2022-11-25T13:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/11/Hologic_Main_Logo_Small_White_cropped-Nxeq8M.jpeg https://medicaex.com/businesswire/hologic-to-showcase-portfolio-of-comprehensive-breast-and-skeletal-health-solutions-at-rsna-2022/ 2022-11-25T13:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/Hologic_Main_Logo_Small_White_cropped-OsFrMw.jpeg https://medicaex.com/businesswire/2022-human-augmentation-market-share-size-trends-report-increasing-adoption-of-wearable-augmentation-products-and-increased-understanding-of-the-therapeutic-benefits-researchandmarkets-com/ 2022-11-25T13:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-UnfvZy.jpeg https://medicaex.com/businesswire/global-antithrombin-market-to-reach-681-million-by-2027-at-a-4-9-cagr-researchandmarkets-com/ 2022-11-25T13:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-3mCfk1.jpeg https://medicaex.com/businesswire/alberto-bonas-exploit-on-the-class40-ibsa-eighth-at-the-route-du-rhum/ 2022-11-25T13:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/11/B7A6947-Okzosf.jpeg https://medicaex.com/businesswire/aptorum-announces-publication-of-a-co-authored-paper-on-development-and-validation-of-a-sensitive-liquid-chromatography-with-time-of-flight-mass-spectrometry-assay-for-in-vivo-pharmacokinetic-study-of/ 2022-11-25T13:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/11/aptorum_hori_HQ-mv3vuI.jpeg https://medicaex.com/businesswire/can-fite-reports-third-quarter-2022-financial-results-provides-clinical-update-3/ 2022-11-25T12:12:11+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo_-_sq_400x400_300dpi_2800229.jpg-X4P425.jpeg https://medicaex.com/businesswire/can-fite-reports-third-quarter-2022-financial-results-provides-clinical-update-2/ 2022-11-25T12:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo_-_sq_400x400_300dpi_2800229.jpg-RHRh8t.jpeg https://medicaex.com/businesswire/2022-polycystic-kidney-disease-drugs-in-development-report-featuring-angion-biomedica-atlas-molecular-pharma-bristol-myers-squibb-and-camurus-among-others-researchandmarkets-com/ 2022-11-25T12:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-3dVksR.jpeg https://medicaex.com/businesswire/global-home-infusion-therapy-market-report-2022-2027-ongoing-enhancements-and-technological-advancements-in-home-infusion-therapy-present-opportunities-researchandmarkets-com/ 2022-11-25T12:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-E418PY.jpeg https://medicaex.com/businesswire/mednow-to-host-quarterly-conference-call-on-tuesday-november-29-2022-at-830am-est-on-its-fourth-quarter-2022-financial-results-2/ 2022-11-25T12:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/11/Mednow_Primary_Horizontal_Logo_5BIcon_2B_Wordmark5D_RGB-lGtfSV.jpeg https://medicaex.com/businesswire/can-fite-reports-third-quarter-2022-financial-results-provides-clinical-update/ 2022-11-25T12:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo_-_sq_400x400_300dpi_2800229.jpg-hzrkT9.jpeg https://medicaex.com/businesswire/global-epadha-omega-3-finished-products-report-data-for-2020-and-2021-with-forecasts-through-2023-researchandmarkets-com/ 2022-11-25T12:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-5g3cyk.jpeg https://medicaex.com/businesswire/mednow-to-host-quarterly-conference-call-on-tuesday-november-29-2022-at-830am-est-on-its-fourth-quarter-2022-financial-results/ 2022-11-25T12:12:03+00:00 https://medicaex.com/wp-content/uploads/2022/11/Mednow_Primary_Horizontal_Logo_5BIcon_2B_Wordmark5D_RGB-Lytvd6.jpeg https://medicaex.com/businesswire/spectrum-pharmaceuticals-receives-complete-response-letter-from-u-s-food-and-drug-administration-for-poziotinib-reaffirms-focus-on-the-commercialization-of-rolvedon-eflapegrastim-xnst-inj-2/ 2022-11-25T11:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/NEW_Logo_Spectrum-cV4ELl.jpeg https://medicaex.com/businesswire/spectrum-pharmaceuticals-receives-complete-response-letter-from-u-s-food-and-drug-administration-for-poziotinib-reaffirms-focus-on-the-commercialization-of-rolvedon-eflapegrastim-xnst-inj/ 2022-11-25T11:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/NEW_Logo_Spectrum-gI7ALf.jpeg https://medicaex.com/businesswire/global-chronic-hepatitis-delta-virus-hdv-infection-drug-pipeline-insight-report-2022-comprehensive-insights-about-10-companies-and-10-pipeline-drugs-researchandmarkets-com/ 2022-11-25T11:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-pFQsVl.jpeg https://medicaex.com/businesswire/iron-deficiency-day-2022-csl-vifor-calls-to-take-iron-seriously-3/ 2022-11-25T06:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/CSLVifor_CMYK_Highres_M01-njDTA5.jpeg https://medicaex.com/businesswire/iron-deficiency-day-2022-csl-vifor-calls-to-take-iron-seriously/ 2022-11-25T06:12:03+00:00 https://medicaex.com/wp-content/uploads/2022/11/CSLVifor_CMYK_Highres_M01-IZBwZr.jpeg https://medicaex.com/businesswire/arcus-biosciences-announces-new-employment-inducement-grants-4/ 2022-11-24T21:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/ARCUS_Logo_RGB_1920x1080-U94i96.jpeg https://medicaex.com/businesswire/arcus-biosciences-announces-new-employment-inducement-grants-3/ 2022-11-24T21:12:03+00:00 https://medicaex.com/wp-content/uploads/2022/11/ARCUS_Logo_RGB_1920x1080-NGRIln.jpeg https://medicaex.com/businesswire/global-hemostasis-diagnostics-market-to-reach-2-7-billion-by-2027-with-a-4-8-cagr-researchandmarkets-com-2/ 2022-11-24T18:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-brHmXe.jpeg https://medicaex.com/businesswire/global-hemostasis-diagnostics-market-to-reach-2-7-billion-by-2027-with-a-4-8-cagr-researchandmarkets-com-3/ 2022-11-24T18:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-hxbvoy.jpeg https://medicaex.com/businesswire/global-hemostasis-diagnostics-market-to-reach-2-7-billion-by-2027-with-a-4-8-cagr-researchandmarkets-com/ 2022-11-24T18:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-dziF16.jpeg https://medicaex.com/businesswire/global-metagenomics-shotgun-sequencing-16s-sequencing-market-size-share-trends-analysis-report-2022-2030-researchandmarkets-com-2/ 2022-11-24T17:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-1lgSDm.jpeg https://medicaex.com/businesswire/global-inflammatory-bowel-disease-drugs-market-to-reach-34-5-billion-by-2031-at-a-5-1-cagr-researchandmarkets-com-2/ 2022-11-24T17:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-jZ2vi9.jpeg https://medicaex.com/businesswire/hospetrack-hospital-intelligence-for-myanmar-2022-opportunities-to-be-found-in-public-private-secondary-care-facilities-researchandmarkets-com/ 2022-11-24T17:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-Uf4O5Q.jpeg https://medicaex.com/businesswire/global-metagenomics-shotgun-sequencing-16s-sequencing-market-size-share-trends-analysis-report-2022-2030-researchandmarkets-com/ 2022-11-24T17:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-uL3Wqr.jpeg https://medicaex.com/businesswire/global-inflammatory-bowel-disease-drugs-market-to-reach-34-5-billion-by-2031-at-a-5-1-cagr-researchandmarkets-com/ 2022-11-24T17:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-Innoda.jpeg https://medicaex.com/businesswire/worldwide-citric-acid-industry-to-2027-featuring-archer-daniels-midland-cargill-rzbc-and-weifang-ensign-industry-among-others-researchandmarkets-com/ 2022-11-24T17:12:03+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-G1C60l.jpeg https://medicaex.com/businesswire/global-transdermal-scopolamine-market-to-reach-528-5-million-by-2027-at-a-5-3-cagr-researchandmarkets-com/ 2022-11-24T16:12:03+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-OBbVu2.jpeg https://medicaex.com/businesswire/non-invasive-prenatal-testing-global-market-report-2022-favourable-reimbursement-scenario-boosts-sector-growth-researchandmarkets-com/ 2022-11-24T15:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-KyO1zO.jpeg https://medicaex.com/businesswire/2-day-pharmaceutical-analytical-method-validation-verification-and-transfer-course-december-13-14-2022-researchandmarkets-com/ 2022-11-24T15:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-Pch4IO.jpeg https://medicaex.com/businesswire/eu-and-us-approach-to-the-development-of-drug-device-and-device-drug-combination-products-2-day-critical-interactions-training-course-february-20-21-2023-researchandmarkets-com-2/ 2022-11-24T14:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-Fr8zhq.jpeg https://medicaex.com/businesswire/eu-and-us-approach-to-the-development-of-drug-device-and-device-drug-combination-products-2-day-critical-interactions-training-course-february-20-21-2023-researchandmarkets-com/ 2022-11-24T14:12:03+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-i9NfsQ.jpeg https://medicaex.com/businesswire/genomics-global-market-report-2022-increasing-demand-for-novel-therapeutics-drives-sector-researchandmarkets-com/ 2022-11-24T13:12:38+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-7gigWT.jpeg https://medicaex.com/businesswire/global-gene-editing-market-report-to-2031-expanding-synthetic-gene-demand-in-various-biotechnology-areas-has-fueled-growth-researchandmarkets-com/ 2022-11-24T13:12:38+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-oKeRdz.jpeg https://medicaex.com/businesswire/worldwide-pharmacy-automation-industry-to-2030-organizations-that-specialize-in-pharmacy-automation-are-looking-for-new-business-prospects-by-increasing-their-presence-in-emerging-markets-research-2/ 2022-11-24T13:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-E38An7.jpeg https://medicaex.com/businesswire/global-medical-ceramics-bioinert-zirconia-aluminium-bioactive-glass-hydroxyapatite-bioresorbable-ceramics-market-research-report-2022-2027-researchandmarkets-com/ 2022-11-24T13:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-DKmYZy.jpeg https://medicaex.com/businesswire/rare-diseases-treatment-global-market-report-2022-dynamically-expanding-orphan-drug-development-scenario-boosts-growth-researchandmarkets-com/ 2022-11-24T13:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-dRIds5.jpeg https://medicaex.com/businesswire/worldwide-pharmacy-automation-industry-to-2030-organizations-that-specialize-in-pharmacy-automation-are-looking-for-new-business-prospects-by-increasing-their-presence-in-emerging-markets-research/ 2022-11-24T13:12:03+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-BqhfIX.jpeg https://medicaex.com/businesswire/latin-america-companion-diagnostics-market-report-to-2028-featuring-almac-biocartis-danaher-ge-healthcare-and-qiagen-among-others-researchandmarkets-com/ 2022-11-24T12:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-aThh6D.jpeg https://medicaex.com/businesswire/portable-medical-electronic-products-technologies-and-global-markets-report-2022-featuring-major-players-philips-panasonic-abbott-hitachi-medical-gn-resound-smith-nephew-nipro-diagnostics-2/ 2022-11-24T12:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-6Vfjw7.jpeg https://medicaex.com/businesswire/portable-medical-electronic-products-technologies-and-global-markets-report-2022-featuring-major-players-philips-panasonic-abbott-hitachi-medical-gn-resound-smith-nephew-nipro-diagnostics/ 2022-11-24T12:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-SEjMft.jpeg https://medicaex.com/businesswire/adalimumab-infliximab-and-etanercept-biosimilars-global-market-report-2022-patent-expiry-driving-sector-growth-researchandmarkets-com/ 2022-11-24T12:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-Fsc9JY.jpeg https://medicaex.com/businesswire/the-worldwide-squalene-industry-is-expected-to-reach-198-million-by-2027-researchandmarkets-com/ 2022-11-24T12:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-q6aEGW.jpeg https://medicaex.com/businesswire/grunenthal-and-kyowa-kirin-international-announce-joint-venture-collaboration-for-established-medicines-portfolio-2/ 2022-11-24T11:15:45+00:00 https://medicaex.com/wp-content/uploads/2022/11/rgbKKI_logo_002-D99Ys0.jpeg https://medicaex.com/businesswire/international-sos-how-to-stay-safe-in-qatar-during-the-world-sport-tournament/ 2022-11-24T11:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/intl_sos_logo-7m9HXv.jpeg https://medicaex.com/businesswire/global-antiviral-drugs-market-report-2022-a-new-approach-to-developing-antiviral-drugs-could-slow-future-viral-outbreaks-and-save-lives-researchandmarkets-com/ 2022-11-24T11:12:03+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-GgMWvE.jpeg https://medicaex.com/businesswire/grunenthal-and-kyowa-kirin-international-announce-joint-venture-collaboration-for-established-medicines-portfolio/ 2022-11-24T11:12:03+00:00 https://medicaex.com/wp-content/uploads/2022/11/rgbKKI_logo_002-1mBHWN.jpeg https://medicaex.com/businesswire/china-fungicides-monthly-real-time-news-service-researchandmarkets-com/ 2022-11-24T10:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-5OEhI3.jpeg https://medicaex.com/businesswire/pediatric-vaccines-global-markets-report-2022-impacts-of-covid-19-market-revenue-data-for-2020-and-2021-estimates-for-2022-and-cagr-projections-through-2027-researchandmarkets-com/ 2022-11-24T10:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-erkhe8.jpeg https://medicaex.com/businesswire/pharmaceutical-industry-in-the-united-states-2022-industry-report-researchandmarkets-com/ 2022-11-24T10:12:03+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-QcUtLO.jpeg https://medicaex.com/businesswire/spectrumx-confirms-next-step-in-clinical-development-of-respiratory-drug-candidate-spx-001-after-mhra-meeting-3/ 2022-11-24T09:12:09+00:00 https://medicaex.com/businesswire/spectrumx-confirms-next-step-in-clinical-development-of-respiratory-drug-candidate-spx-001-after-mhra-meeting-2/ 2022-11-24T09:12:07+00:00 https://medicaex.com/businesswire/spectrumx-confirms-next-step-in-clinical-development-of-respiratory-drug-candidate-spx-001-after-mhra-meeting/ 2022-11-24T09:12:05+00:00 https://medicaex.com/businesswire/foxo-technologies-announces-filing-of-form-10-q-for-the-third-quarter-2022-2/ 2022-11-24T00:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/FOXO-Black-tqERMk.jpeg https://medicaex.com/businesswire/icon-plc-to-present-at-the-2022-evercore-isi-healthconx-conference-2/ 2022-11-23T22:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/ICON_Positive_logo_PNG_28nostrap29-X2jZrP.jpeg https://medicaex.com/businesswire/icon-plc-to-present-at-the-2022-evercore-isi-healthconx-conference/ 2022-11-23T22:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/ICON_Positive_logo_PNG_28nostrap29-jplE6M.jpeg https://medicaex.com/businesswire/omnicell-to-present-at-the-piper-sandler-34th-annual-healthcare-conference-2/ 2022-11-23T21:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/01_omnicell_lockup_horizontal_green_rgb-5DvKaf.jpeg https://medicaex.com/businesswire/omnicell-to-present-at-the-piper-sandler-34th-annual-healthcare-conference/ 2022-11-23T21:12:03+00:00 https://medicaex.com/wp-content/uploads/2022/11/01_omnicell_lockup_horizontal_green_rgb-iRi1Fc.jpeg https://medicaex.com/businesswire/inflow-a-science-based-app-for-adhd-announces-acquisition-of-lina/ 2022-11-23T19:12:07+00:00 https://medicaex.com/businesswire/genexa-the-first-clean-medicine-company-stands-behind-its-advertising-claims-and-appeals-adverse-ruling-by-nad-3/ 2022-11-23T18:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/genexa_lockup_black-EmsVKb.jpeg https://medicaex.com/businesswire/yes-hearing-announces-expansion-of-integrated-home-based-care-services-for-health-plans-3/ 2022-11-23T18:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/11/Yes_Logo_1-bK30gR.jpeg https://medicaex.com/businesswire/yes-hearing-announces-expansion-of-integrated-home-based-care-services-for-health-plans-2/ 2022-11-23T18:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/11/Yes_Logo_1-KInDKP.jpeg https://medicaex.com/businesswire/genexa-the-first-clean-medicine-company-stands-behind-its-advertising-claims-and-appeals-adverse-ruling-by-nad/ 2022-11-23T18:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/genexa_lockup_black-bLeMMB.jpeg https://medicaex.com/businesswire/global-cardiomyopathies-market-report-to-2031-featuring-astrazeneca-merck-novartis-sanofi-and-abbott-among-others-researchandmarkets-com/ 2022-11-23T18:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-etwkZh.jpeg https://medicaex.com/businesswire/yes-hearing-announces-expansion-of-integrated-home-based-care-services-for-health-plans/ 2022-11-23T18:12:03+00:00 https://medicaex.com/wp-content/uploads/2022/11/Yes_Logo_1-jbWXyh.jpeg https://medicaex.com/businesswire/france-eib-and-medincell-sign-a-new-e40-million-loan-agreement-to-support-development-of-innovative-treatments-2/ 2022-11-23T17:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/Logo_MedinCell_registered-iLizox.jpeg https://medicaex.com/businesswire/global-protein-expression-market-size-share-industry-trends-analysis-report-by-system-product-application-end-user-regional-outlook-and-forecast-2022-2028-2/ 2022-11-23T17:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-TLyB5Y.jpeg https://medicaex.com/businesswire/france-eib-and-medincell-sign-a-new-e40-million-loan-agreement-to-support-development-of-innovative-treatments/ 2022-11-23T17:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/Logo_MedinCell_registered-6k0yJk.jpeg https://medicaex.com/businesswire/global-protein-expression-market-size-share-industry-trends-analysis-report-by-system-product-application-end-user-regional-outlook-and-forecast-2022-2028/ 2022-11-23T17:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-yo36IH.jpeg https://medicaex.com/businesswire/digital-marketing-trends-in-hepatocellular-carcinoma-2022-featuring-merck-co-bristol-myers-squibb-genentech-eli-lilly-exelixis-eisai-researchandmarkets-com-2/ 2022-11-23T16:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-BOtA0o.jpeg https://medicaex.com/businesswire/digital-marketing-trends-in-hepatocellular-carcinoma-2022-featuring-merck-co-bristol-myers-squibb-genentech-eli-lilly-exelixis-eisai-researchandmarkets-com/ 2022-11-23T16:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-TqUNuk.jpeg https://medicaex.com/businesswire/high-level-disinfectants-terminal-sterilization-services-global-market-report-2022-rising-number-of-surgical-and-minimally-invasive-aesthetic-operations-driving-growth-researchandmarkets-com/ 2022-11-23T16:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-3wokzg.jpeg https://medicaex.com/businesswire/nocd-educates-record-number-of-people-during-2022-ocd-awareness-month/ 2022-11-23T16:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/11/NOCD-Logo-LnzKTM.jpeg https://medicaex.com/businesswire/global-cell-separation-technologies-market-report-to-2029-featuring-bio-techne-merck-ge-healthcare-and-stemcell-technologies-among-others-researchandmarkets-com/ 2022-11-23T15:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-Hr1E9h.jpeg https://medicaex.com/businesswire/worldwide-life-science-analytics-industry-to-2029-increasing-acceptance-of-analytics-solutions-in-clinical-trials-is-driving-growth-researchandmarkets-com/ 2022-11-23T15:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-cuEJvk.jpeg https://medicaex.com/businesswire/clinical-laboratory-service-global-market-report-2022-growing-prevalence-of-target-diseases-coupled-with-rising-demand-for-early-disease-diagnostic-tests-fuels-sector-researchandmarkets-com-3/ 2022-11-23T15:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-TY7uGi.jpeg https://medicaex.com/businesswire/clinical-laboratory-service-global-market-report-2022-growing-prevalence-of-target-diseases-coupled-with-rising-demand-for-early-disease-diagnostic-tests-fuels-sector-researchandmarkets-com/ 2022-11-23T15:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-xOZjti.jpeg https://medicaex.com/businesswire/clinical-laboratory-service-global-market-report-2022-growing-prevalence-of-target-diseases-coupled-with-rising-demand-for-early-disease-diagnostic-tests-fuels-sector-researchandmarkets-com-2/ 2022-11-23T15:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-ARYuiM.jpeg https://medicaex.com/businesswire/global-audiology-devices-market-report-2022-government-initiatives-about-hearing-screening-among-infants-and-older-adults-presents-opportunities-researchandmarkets-com/ 2022-11-23T15:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-rglcpa.jpeg https://medicaex.com/businesswire/glaucoma-therapeutics-global-market-report-2022-development-of-innovative-combination-drugs-sparks-sector-growth-researchandmarkets-com/ 2022-11-23T15:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-sjVfiN.jpeg https://medicaex.com/businesswire/304-billion-worldwide-monoclonal-antibodies-industry-to-2027-featuring-abbvie-amgen-biogen-gsk-johnson-johnson-and-sanofi-among-others-researchandmarkets-com-2/ 2022-11-23T14:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-aOd3ii.jpeg https://medicaex.com/businesswire/global-biphenyl-market-report-2022-wide-applications-across-textiles-and-pharmaceuticals-fuels-growth-researchandmarkets-com-2/ 2022-11-23T14:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-KpgzvL.jpeg https://medicaex.com/businesswire/btig-to-host-ophthalmology-day-on-november-29-2022/ 2022-11-23T14:12:10+00:00 https://medicaex.com/businesswire/feinstein-institutes-awarded-3-6m-from-new-york-state-for-spinal-cord-injury-research-3/ 2022-11-23T14:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/Bouton_News-PK3c5F.jpeg https://medicaex.com/businesswire/modivcare-to-present-at-the-bofa-securities-home-care-conference-2022/ 2022-11-23T14:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/Modivcare_Primary-1200x600-903638b-8N4J5Y.jpeg https://medicaex.com/businesswire/feinstein-institutes-awarded-3-6m-from-new-york-state-for-spinal-cord-injury-research-2/ 2022-11-23T14:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/Bouton_News-jC4LBS.jpeg https://medicaex.com/businesswire/airtank-announces-carecart-a-first-of-its-kind-ecommerce-platform-built-exclusively-for-the-healthcare-and-medical-technology-sectors-3/ 2022-11-23T14:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/CareCart_CART_LOGO_No_Text-bdkbnT.jpeg https://medicaex.com/businesswire/feinstein-institutes-awarded-3-6m-from-new-york-state-for-spinal-cord-injury-research/ 2022-11-23T14:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/11/Bouton_News-fY4OKN.jpeg https://medicaex.com/businesswire/airtank-announces-carecart-a-first-of-its-kind-ecommerce-platform-built-exclusively-for-the-healthcare-and-medical-technology-sectors-2/ 2022-11-23T14:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/11/CareCart_CART_LOGO_No_Text-OAF26t.jpeg https://medicaex.com/businesswire/airtank-announces-carecart-a-first-of-its-kind-ecommerce-platform-built-exclusively-for-the-healthcare-and-medical-technology-sectors/ 2022-11-23T14:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/CareCart_CART_LOGO_No_Text-kzDTxZ.jpeg https://medicaex.com/businesswire/global-biphenyl-market-report-2022-wide-applications-across-textiles-and-pharmaceuticals-fuels-growth-researchandmarkets-com/ 2022-11-23T14:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-Cpb05Y.jpeg https://medicaex.com/businesswire/global-liver-disease-market-report-2022-high-prevalence-of-liver-diseases-driving-sector-growth-researchandmarkets-com/ 2022-11-23T14:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-8aELlA.jpeg https://medicaex.com/businesswire/china-bispecific-antibody-market-opportunity-clinical-trials-report-2022-2028-comprehensive-insights-on-more-than-80-bispecific-antibodies-available-for-licensing-partnership-researchandmarke/ 2022-11-23T14:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-N5iTFe.jpeg https://medicaex.com/businesswire/304-billion-worldwide-monoclonal-antibodies-industry-to-2027-featuring-abbvie-amgen-biogen-gsk-johnson-johnson-and-sanofi-among-others-researchandmarkets-com/ 2022-11-23T14:12:03+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-EPrO4c.jpeg https://medicaex.com/businesswire/amneal-to-participate-at-upcoming-investor-conferences-2/ 2022-11-23T13:12:12+00:00 https://medicaex.com/wp-content/uploads/2022/11/amneallogo-QyUmB9.jpeg https://medicaex.com/businesswire/gamida-cell-to-present-corporate-highlights-at-multiple-upcoming-investor-conferences-2/ 2022-11-23T13:12:12+00:00 https://medicaex.com/wp-content/uploads/2022/11/Gamida-Cell-Logo_Sept2022-Teq8fl.jpeg https://medicaex.com/businesswire/novocure-to-participate-in-34th-annual-piper-sandler-healthcare-conference-2/ 2022-11-23T13:12:11+00:00 https://medicaex.com/wp-content/uploads/2022/11/novocure_main405x-5CQal1.jpeg https://medicaex.com/businesswire/atara-biotherapeutics-to-participate-at-the-evercore-isi-5th-annual-healthconx-conference-2/ 2022-11-23T13:12:11+00:00 https://medicaex.com/wp-content/uploads/2022/11/Atara-Bio1_logo_300x185-1-osLwji.jpeg https://medicaex.com/businesswire/twist-bioscience-to-present-at-5th-annual-evercore-isi-healthconx-conference-2/ 2022-11-23T13:12:11+00:00 https://medicaex.com/wp-content/uploads/2022/11/Twist_Bioscience_Logo-sww9JA.jpeg https://medicaex.com/businesswire/digital-therapeutics-dtx-market-report-2022-increasing-demand-for-digital-delivery-of-behavioral-therapy-drives-growth-researchandmarkets-com/ 2022-11-23T13:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-RN333O.jpeg https://medicaex.com/businesswire/500-million-worldwide-tumor-ablation-therapy-devices-industry-to-2031-increasing-prevalence-of-cancer-is-a-key-driving-factor-researchandmarkets-com/ 2022-11-23T13:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-B59qce.jpeg https://medicaex.com/businesswire/2022-monkeypox-testing-market-research-report-researchandmarkets-com/ 2022-11-23T13:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-RtwfW3.jpeg https://medicaex.com/businesswire/rite-aid-announces-early-results-of-previously-announced-cash-tender-offer-for-7-500-senior-secured-notes-due-2025-and-extension-of-early-tender-premium/ 2022-11-23T13:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/11/RAD-Logo-PMS-DYVSza.jpeg https://medicaex.com/businesswire/gamida-cell-to-present-corporate-highlights-at-multiple-upcoming-investor-conferences/ 2022-11-23T13:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/Gamida-Cell-Logo_Sept2022-EzvUrU.jpeg https://medicaex.com/businesswire/novocure-to-participate-in-34th-annual-piper-sandler-healthcare-conference/ 2022-11-23T13:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/novocure_main405x-EIiFGY.jpeg https://medicaex.com/businesswire/atara-biotherapeutics-to-participate-at-the-evercore-isi-5th-annual-healthconx-conference/ 2022-11-23T13:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/Atara-Bio1_logo_300x185-1-jArukK.jpeg https://medicaex.com/businesswire/twist-bioscience-to-present-at-5th-annual-evercore-isi-healthconx-conference/ 2022-11-23T13:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/Twist_Bioscience_Logo-EjRElA.jpeg https://medicaex.com/businesswire/amneal-to-participate-at-upcoming-investor-conferences/ 2022-11-23T13:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/amneallogo-arL0nH.jpeg https://medicaex.com/businesswire/sage-therapeutics-to-present-at-the-piper-sandler-34th-annual-healthcare-conference-2/ 2022-11-23T12:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/Sage_Logo-hymBF4.jpeg https://medicaex.com/businesswire/sage-therapeutics-to-present-at-the-piper-sandler-34th-annual-healthcare-conference/ 2022-11-23T12:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/Sage_Logo-IFIAHv.jpeg https://medicaex.com/businesswire/xeris-biopharma-announces-research-collaboration-and-option-agreement-with-horizon-therapeutics-plc-for-xeriject-formulation-of-teprotumumab-2/ 2022-11-23T11:12:08+00:00 https://medicaex.com/businesswire/the-worldwide-single-use-consumables-industry-is-projected-to-reach-4-7-billion-by-2027-researchandmarkets-com/ 2022-11-23T11:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-KhZTcI.jpeg https://medicaex.com/businesswire/xeris-biopharma-announces-research-collaboration-and-option-agreement-with-horizon-therapeutics-plc-for-xeriject-formulation-of-teprotumumab/ 2022-11-23T11:12:04+00:00 https://medicaex.com/businesswire/the-native-antigen-company-strengthens-senior-team-to-support-growing-product-portfolio-2/ 2022-11-23T10:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/New_Logo_V1_2800229-FrcFVK.jpeg https://medicaex.com/businesswire/global-real-world-evidence-solutions-market-report-2022-shift-from-volume-to-value-based-care-drives-growth-researchandmarkets-com/ 2022-11-23T10:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-jTapuA.jpeg https://medicaex.com/businesswire/the-native-antigen-company-strengthens-senior-team-to-support-growing-product-portfolio/ 2022-11-23T10:12:03+00:00 https://medicaex.com/wp-content/uploads/2022/11/New_Logo_V1_2800229-OPHP21.jpeg https://medicaex.com/businesswire/leading-japanese-pharmaceutical-company-shionogi-officially-opens-doors-of-its-new-european-headquarters-in-amsterdam-2/ 2022-11-23T09:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/Blue_Herengracht-zuYuiz.jpeg https://medicaex.com/businesswire/bit-bio-expands-its-portfolio-with-three-new-human-cell-products-for-research-and-drug-discovery-in-neurodegenerative-and-neurological-diseases-2/ 2022-11-23T09:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/ioGABA_12_day_2_final-yARnYQ.jpeg https://medicaex.com/businesswire/bit-bio-expands-its-portfolio-with-three-new-human-cell-products-for-research-and-drug-discovery-in-neurodegenerative-and-neurological-diseases/ 2022-11-23T09:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/ioGABA_12_day_2_final-IFpiyV.jpeg https://medicaex.com/businesswire/leading-japanese-pharmaceutical-company-shionogi-officially-opens-doors-of-its-new-european-headquarters-in-amsterdam/ 2022-11-23T09:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/Blue_Herengracht-GnbgEe.jpeg https://medicaex.com/businesswire/spravato%e2%96%bc-esketamine-nasal-spray-data-from-the-phase-3b-escape-trd-study-demonstrate-superior-efficacy-compared-to-quetiapine-extended-release-in-treatment-resistant-major-depressive-d-2/ 2022-11-23T08:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/Janssen_Neuroscience_logo-I931tL.jpeg https://medicaex.com/businesswire/iktos-partners-with-medicines-for-malaria-venture-in-anti-malarial-drug-discovery-3/ 2022-11-23T08:12:08+00:00 https://medicaex.com/businesswire/iktos-partners-with-medicines-for-malaria-venture-in-anti-malarial-drug-discovery-2/ 2022-11-23T08:12:06+00:00 https://medicaex.com/businesswire/iktos-partners-with-medicines-for-malaria-venture-in-anti-malarial-drug-discovery/ 2022-11-23T08:12:04+00:00 https://medicaex.com/businesswire/spravato%e2%96%bc-esketamine-nasal-spray-data-from-the-phase-3b-escape-trd-study-demonstrate-superior-efficacy-compared-to-quetiapine-extended-release-in-treatment-resistant-major-depressive-d/ 2022-11-23T08:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/Janssen_Neuroscience_logo-xa1lZc.jpeg https://medicaex.com/businesswire/medigram-leads-mobile-medicine-technology-ecosystem-partnering-with-routledge-taylor-francis-on-a-new-book-series-and-announces-new-book-advanced-health-technology-our-second-consecutive-book-4/ 2022-11-23T04:12:13+00:00 https://medicaex.com/wp-content/uploads/2022/11/Medigram_logo-7wYnhB.jpeg https://medicaex.com/businesswire/medigram-leads-mobile-medicine-technology-ecosystem-partnering-with-routledge-taylor-francis-on-a-new-book-series-and-announces-new-book-advanced-health-technology-our-second-consecutive-book-3/ 2022-11-23T04:12:11+00:00 https://medicaex.com/wp-content/uploads/2022/11/Medigram_logo-BkAAJl.jpeg https://medicaex.com/businesswire/medigram-leads-mobile-medicine-technology-ecosystem-partnering-with-routledge-taylor-francis-on-a-new-book-series-and-announces-new-book-advanced-health-technology-our-second-consecutive-book-2/ 2022-11-23T04:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/11/Medigram_logo-wllbx9.jpeg https://medicaex.com/businesswire/medigram-leads-mobile-medicine-technology-ecosystem-partnering-with-routledge-taylor-francis-on-a-new-book-series-and-announces-new-book-advanced-health-technology-our-second-consecutive-book/ 2022-11-23T04:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/11/Medigram_logo-nHpDP1.jpeg https://medicaex.com/businesswire/2022-radiological-society-of-north-america-rsna-annual-meeting-bayer-to-showcase-product-offerings-and-announces-broadened-ai-offering-in-radiology-2/ 2022-11-23T02:12:24+00:00 https://medicaex.com/wp-content/uploads/2022/11/Bayer_Logo-Pstpq8.jpeg https://medicaex.com/businesswire/2022-radiological-society-of-north-america-rsna-annual-meeting-bayer-to-showcase-product-offerings-and-announces-broadened-ai-offering-in-radiology/ 2022-11-23T02:12:15+00:00 https://medicaex.com/wp-content/uploads/2022/11/Bayer_Logo-mwlimf.jpeg https://medicaex.com/businesswire/wellbeing-digital-announces-the-appointment-of-mohammad-sharifi-to-board-of-directors-2/ 2022-11-22T23:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/61eb51c1cab991b7cbdd437e_Wellbeing_-_2col-hVNj6J.jpeg https://medicaex.com/businesswire/wellbeing-digital-announces-the-appointment-of-mohammad-sharifi-to-board-of-directors/ 2022-11-22T23:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/61eb51c1cab991b7cbdd437e_Wellbeing_-_2col-QvP2hK.jpeg https://medicaex.com/businesswire/alpine-immune-sciences-announces-participation-in-fireside-chat-at-the-5th-annual-evercore-isi-healthconx-conference-2/ 2022-11-22T22:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/11/AIS-Logo-YrLOQa.jpeg https://medicaex.com/businesswire/ge-announces-closing-of-offering-of-8-25-billion-senior-notes-issued-by-ge-healthcare/ 2022-11-22T22:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/GEMongram28Blue-PMS745529300dpi-0Q4hSh.jpeg https://medicaex.com/businesswire/alpine-immune-sciences-announces-participation-in-fireside-chat-at-the-5th-annual-evercore-isi-healthconx-conference/ 2022-11-22T22:12:03+00:00 https://medicaex.com/wp-content/uploads/2022/11/AIS-Logo-8gI4ML.jpeg https://medicaex.com/businesswire/amneal-launches-second-biosimilar-with-releuko-filgrastim-ayow-in-the-united-states-2/ 2022-11-22T21:12:11+00:00 https://medicaex.com/wp-content/uploads/2022/11/amneallogo-x2T3i7.jpeg https://medicaex.com/businesswire/savara-announces-new-employment-inducement-grant-2/ 2022-11-22T21:12:11+00:00 https://medicaex.com/wp-content/uploads/2022/11/Savara_Logo_2800229-PUDNUy.jpeg https://medicaex.com/businesswire/takedas-biologics-license-application-bla-for-dengue-vaccine-candidate-tak-003-granted-priority-review-by-u-s-food-and-drug-administration-2/ 2022-11-22T21:12:11+00:00 https://medicaex.com/wp-content/uploads/2022/11/takeda-logo_FULL-YGvsJw.jpeg https://medicaex.com/businesswire/justin-mika-joins-phenovista-biosciences-board-of-advisors/ 2022-11-22T21:12:11+00:00 https://medicaex.com/businesswire/conmed-corporation-to-participate-in-a-fireside-chat-at-the-34th-annual-piper-sander-healthcare-conference-2/ 2022-11-22T21:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/ConMed_LogoPMS3005_RGB-K7LJ3C.jpeg https://medicaex.com/businesswire/veradigm-digital-health-media-becomes-the-first-ehr-marketing-solution-to-join-the-point-of-care-marketing-association-2/ 2022-11-22T21:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/Allscripts-Logo-h6KjeV.jpeg https://medicaex.com/businesswire/conmed-corporation-to-participate-in-a-fireside-chat-at-the-34th-annual-piper-sander-healthcare-conference/ 2022-11-22T21:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/ConMed_LogoPMS3005_RGB-tr3NmG.jpeg https://medicaex.com/businesswire/ironwood-pharmaceuticals-to-participate-in-the-piper-sandler-34th-annual-healthcare-conference/ 2022-11-22T21:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/IRWD_Logo_Color_Vertical_RD_RGB-HZkSJg.jpeg https://medicaex.com/businesswire/takedas-biologics-license-application-bla-for-dengue-vaccine-candidate-tak-003-granted-priority-review-by-u-s-food-and-drug-administration/ 2022-11-22T21:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/takeda-logo_FULL-Z5PSC5.jpeg https://medicaex.com/businesswire/amneal-launches-second-biosimilar-with-releuko-filgrastim-ayow-in-the-united-states/ 2022-11-22T21:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/amneallogo-ZSxg1l.jpeg https://medicaex.com/businesswire/savara-announces-new-employment-inducement-grant/ 2022-11-22T21:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/Savara_Logo_2800229-Kl4sWp.jpeg https://medicaex.com/businesswire/veradigm-digital-health-media-becomes-the-first-ehr-marketing-solution-to-join-the-point-of-care-marketing-association/ 2022-11-22T21:12:03+00:00 https://medicaex.com/wp-content/uploads/2022/11/Allscripts-Logo-TnOx14.jpeg https://medicaex.com/businesswire/heroic-cybersecurity-wins-national-healthcare-merit-award/ 2022-11-22T20:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/11/Merit_SILVER_HealthTech-HEROIC-wiXJML.jpeg https://medicaex.com/businesswire/tevogen-bio-to-study-therapeutic-potential-of-its-investigational-covid-19-t-cell-therapy-in-long-covid-2/ 2022-11-22T19:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/Tevogen_Logo_800px-4eM40j.jpeg https://medicaex.com/businesswire/biotek-remedys-promotes-awareness-and-education-on-national-family-health-history-day/ 2022-11-22T19:12:04+00:00 https://medicaex.com/businesswire/tevogen-bio-to-study-therapeutic-potential-of-its-investigational-covid-19-t-cell-therapy-in-long-covid/ 2022-11-22T19:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/Tevogen_Logo_800px-D6dYfs.jpeg https://medicaex.com/businesswire/ahf-sues-apexus-over-failed-340b-drug-price-negotiations/ 2022-11-22T19:12:03+00:00 https://medicaex.com/wp-content/uploads/2022/11/20221118_AHF_v_Apexus_Complaint-sCxvoI.jpeg https://medicaex.com/businesswire/the-brain-foundation-advances-life-sciences-research-and-biopharma-for-autism-2/ 2022-11-22T18:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/The_BRAIN_Foundation_Logo-jGCQav.jpeg https://medicaex.com/businesswire/the-brain-foundation-advances-life-sciences-research-and-biopharma-for-autism/ 2022-11-22T18:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/The_BRAIN_Foundation_Logo-04aWzf.jpeg https://medicaex.com/businesswire/recode-therapeutics-to-present-at-upcoming-investor-conferences-in-2022-2/ 2022-11-22T17:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/ReCode_Logo_Primary_Web402000px-t2V6L4.jpeg https://medicaex.com/businesswire/acticor-biotech-worlds-first-clinical-trial-to-test-new-drug-glenzocimab-for-heart-attacks-2/ 2022-11-22T17:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/Acticor_Biotech-tEF73u.jpeg https://medicaex.com/businesswire/median-technologies-to-speak-at-the-radiological-society-of-north-america-rsna-2022-annual-meeting-nov-27-dec-1-chicago-il-usa-with-three-presentations-2/ 2022-11-22T17:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/Median_RGB-69mVG3.jpeg https://medicaex.com/businesswire/median-technologies-to-speak-at-the-radiological-society-of-north-america-rsna-2022-annual-meeting-nov-27-dec-1-chicago-il-usa-with-three-presentations/ 2022-11-22T17:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/11/Median_RGB-j8YJnX.jpeg https://medicaex.com/businesswire/acticor-biotech-worlds-first-clinical-trial-to-test-new-drug-glenzocimab-for-heart-attacks/ 2022-11-22T17:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/Acticor_Biotech-9W7pK3.jpeg https://medicaex.com/businesswire/global-intranasal-drug-and-vaccine-delivery-market-report-2022-rising-prevalence-of-respiratory-and-neurological-diseases-fuels-growth-researchandmarkets-com/ 2022-11-22T17:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-Uk2oeX.jpeg https://medicaex.com/businesswire/recode-therapeutics-to-present-at-upcoming-investor-conferences-in-2022/ 2022-11-22T17:12:03+00:00 https://medicaex.com/wp-content/uploads/2022/11/ReCode_Logo_Primary_Web402000px-VOiMqF.jpeg https://medicaex.com/businesswire/cellworks-therapy-biosimulation-study-reveals-promising-new-biomarkers-for-tmz-resistance-in-glioblastoma-patients-2/ 2022-11-22T16:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/Cellworks_logo_-_white_backgrond_orange_tagline-lQezqD.jpeg https://medicaex.com/businesswire/cellworks-therapy-biosimulation-study-reveals-promising-new-biomarkers-for-tmz-resistance-in-glioblastoma-patients/ 2022-11-22T16:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/Cellworks_logo_-_white_backgrond_orange_tagline-0XKzur.jpeg https://medicaex.com/businesswire/global-pregabalin-market-research-report-to-2027-featuring-lupin-medley-pharmaceuticals-novartis-and-pfizer-among-others-researchandmarkets-com/ 2022-11-22T16:12:03+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-ahjVoQ.jpeg https://medicaex.com/businesswire/dermavant-launches-first-commercial-for-vtama-tapinarof-cream-1-as-part-of-a-national-multimedia-campaign-for-adults-with-plaque-psoriasis-2/ 2022-11-22T15:12:09+00:00 https://medicaex.com/businesswire/global-synthetic-biology-market-2022-2028-continuous-investment-in-rd-drives-32-annual-growth-researchandmarkets-com-2/ 2022-11-22T15:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-fHkXPT.jpeg https://medicaex.com/businesswire/global-fertility-test-market-report-2022-launch-of-accurate-easy-to-use-testing-drives-growth-researchandmarkets-com/ 2022-11-22T15:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-aGa41g.jpeg https://medicaex.com/businesswire/collective-health-announces-chris-newman-as-chief-financial-officer/ 2022-11-22T15:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/11/Collective_Health_Logo-msS2wp.jpeg https://medicaex.com/businesswire/choicespine-announces-line-extension-of-their-harrier-stand-alone-anterior-lumbar-interbody-fusion-system/ 2022-11-22T15:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/11/harrier_stg_cover_splash-cY0nWG.jpeg https://medicaex.com/businesswire/global-synthetic-biology-market-2022-2028-continuous-investment-in-rd-drives-32-annual-growth-researchandmarkets-com/ 2022-11-22T15:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-NbS1DZ.jpeg https://medicaex.com/businesswire/clinical-evidence-shows-reduced-costs-and-improved-outcomes-in-heart-transplantation/ 2022-11-22T14:12:13+00:00 https://medicaex.com/wp-content/uploads/2022/11/Removing_Heart_in_OR-tD8y9Q.jpeg https://medicaex.com/businesswire/cel-sci-corporation-issues-letter-to-shareholders/ 2022-11-22T14:12:13+00:00 https://medicaex.com/wp-content/uploads/2022/11/CEL-SCI_Logo-gaWH6p.jpeg https://medicaex.com/businesswire/comprehensive-single-cell-technology-2022-10x-genomics-fluidigm-bd-biosciences-and-berkeley-light-lead-the-way-in-fast-growing-sector-researchandmarkets-com/ 2022-11-22T14:12:13+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-N3IEwG.jpeg https://medicaex.com/businesswire/fujifilm-invests-188-million-in-new-cell-culture-media-manufacturing-facility-3/ 2022-11-22T14:12:12+00:00 https://medicaex.com/wp-content/uploads/2022/11/FUJIFILM_VFI_lores_282029-O8BIhx.jpeg https://medicaex.com/businesswire/dexcom-announces-upcoming-conference-presentation-2/ 2022-11-22T14:12:12+00:00 https://medicaex.com/wp-content/uploads/2022/11/Dexcom_Registered_no_bug-dJBTZq.jpeg https://medicaex.com/businesswire/new-survey-from-betterhelp-reveals-nearly-half-of-americans-are-worried-about-their-mental-health-this-holiday-season-2/ 2022-11-22T14:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/11/betterhelp-logo-Px49x5.jpeg https://medicaex.com/businesswire/exo-cfo-lori-munoz-wins-stevie-award-for-women-in-business-2/ 2022-11-22T14:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/11/Exo_Logo_Horizontal-Xo5itE.jpeg https://medicaex.com/businesswire/over-100-hospitals-now-directly-connected-and-live-on-hietexas-eden-network/ 2022-11-22T14:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/PointClickCareLogoCMYK-3UnuFu.jpeg https://medicaex.com/businesswire/dexcom-announces-upcoming-conference-presentation/ 2022-11-22T14:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/Dexcom_Registered_no_bug-doaWdJ.jpeg https://medicaex.com/businesswire/blue-earth-diagnostics-highlights-presentations-on-axumin-fluciclovine-f-18-at-upcoming-rsna-2022-annual-meeting-2/ 2022-11-22T14:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/BED_Bracco_28RGB29-oPysSt.jpeg